Back to discover
Drug

Citric Acid

In clinical development
Emerging researchLate-stage development
Also known as 2-Hydroxytricarballylic acid, Acidum citricum, Alka-Seltzer, Bicitra+28 more

2-Hydroxytricarballylic acid, Acidum citricum, Alka-Seltzer, Bicitra, Bromo Seltzer Antacid Pain Reliever, Citronensäure, Clenpiq, Cytra 2, Cytra-2, Cytra-3, Cytra-K, E-Z-Gas II, K+Care ET, Liqui-Dualcitra, Oracit, Phexx, Phexxi, Picot, Polycitra, Polycitra-K, Polycitra-LC, Prepopik, Renacidin, Urologic G, ácido cítrico, 2-hydroxy-1,2,3-propanetricarboxyic acid, 3-carboxy-3-hydroxypentane-1,5-dioic acid, Citric Acid-Potassium Citrate, Citric Acid-Sodium Citrate, Potassium Citrate-Citric Acid, Potassium Citrate-Sodium Citrate-Citric Acid, Sodium Citrate Dihydrate.

2
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

A Cross-sectional Study to Measure Cough in Severe Asthma

Clinical trial2023-11-22Results posted · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Citric Acid
Aliases & brands
2-Hydroxytricarballylic acidAcidum citricumAlka-SeltzerBicitraBromo Seltzer Antacid Pain RelieverCitronensäureClenpiqCytra 2Cytra-2Cytra-3Cytra-KE-Z-Gas IIK+Care ETLiqui-DualcitraOracitPhexxPhexxiPicotPolycitraPolycitra-KPolycitra-LCPrepopikRenacidinUrologic Gácido cítrico2-hydroxy-1,2,3-propanetricarboxyic acid3-carboxy-3-hydroxypentane-1,5-dioic acidCitric Acid-Potassium CitrateCitric Acid-Sodium CitratePotassium Citrate-Citric AcidPotassium Citrate-Sodium Citrate-Citric AcidSodium Citrate Dihydrate
RxNorm CUI
21183
ChEMBL ID
CHEMBL2107737
UNII
2968PHW8QP

Clinical trials

4 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
4
registered trials across all phases
LATEST COMPLETION 2019
4
Late-stage (III+)
3
Completed
1
Discontinued
PHASE DISTRIBUTIONn = 4
Phase 41Phase N / A3

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20202023
Major research themes2
Aspergillus niger1Citric Acid1
Journals, researchers & institutions
Top journals
  • Molecules (Basel, Switzerland)1
  • Nature communications1
Leading researchers
  • Baseler WA1
  • Cassel T1
  • Davies LC1
  • Fan TW1
  • Ghesquière B1
  • Gonzalez-Cotto M1
  • Higashi RM1
  • Książek E1
Leading institutions
free-text, unnormalised
  • Department of Toxicology and Cancer Biology and Markey Cancer Center and Center for Environmental and Systems Biochemistry1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development1
  • Metabolomics Expertise Center1
  • National Cancer Institute1
  • School of Cellular and Molecular Medicine1
  • School of Medicine1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as Citric Acid in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials